{
  "ptid_time": "073_S_4986_2012-10-04",
  "img_path": "/data/qiuhui/data/adni/images/073_S_4986/2012-10-04/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 71,559 mm³, 52.2% above the reference mean. With a Z-score of 1.52 (93.5th percentile), this represents moderate enlargement; whole brain volume measures 916,150 mm³, 11.0% below the reference mean. With a Z-score of -1.44 (7.5th percentile), this represents mild atrophy. ",
  "text_data": "Age is 85.3 years. Gender is Male. Education: 20 years. Handedness: Right. Race: White. Medical history: Psychiatric; Musculoskeletal; Endocrine-Metabolic; Gastrointestinal; Hematopoietic-Lymphatic; Renal-Genitourinary; Allergies or Drug Sensitivities; Smoking; Major Surgical Procedures. MMSE: 28.0. MoCA: 23.0. Logical Memory: 10.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.13 SUVR (normal ); Amyloid beta: 780.50 pg/mL (normal ); Total tau: 142.90 pg/mL (mild reduced); Phosphorylated tau: 11.27 pg/mL (mild reduced). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient shows moderate ventricular enlargement and mild whole brain atrophy, which are structural changes often seen in neurodegenerative conditions. Despite normal Aβ levels and mildly reduced tau markers, the cognitive scores (MMSE 28, MoCA 23) suggest mild cognitive impairment (MCI), particularly given the MoCA score below the typical cutoff of 26.  \n\n**Diagnosis:** MCI  \n**Confidence:** Medium (due to conflicting biomarkers—normal Aβ but structural and cognitive decline)",
  "timestamp": "2025-07-26T09:54:08.556546"
}